Matt Larew

Work Performance Price Targets & Ratings Chart

Analyst Matt Larew, currently employed at WILLIAM BLAIR,

Most recent stock forecast was given on DNA, Ginkgo Bioworks Holdings at 16-Oct-2025.

Wall Street Analyst Matt Larew

Analyst best performing recommendations are on DNA (GINKGO BIOWORKS HOLDINGS).
DNA Ginkgo Bioworks Holdings INNV InnovAge Holding Corp SGFY Signify Health ZY Zymergen MRVI Maravai Lifesciences Holdings  DVA DaVita HealthCare Partners MXCT MaxCyte

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Sell

$9

$-4.52 (-33.43%)

$7

1 months 21 days ago
(24-Aug-2025)

2/5 (40%)

$-3.05 (-25.31%)

31

Sell

$12

$-1.52 (-11.24%)

$44

1 years 3 months 7 days ago
(08-Jul-2024)

3/4 (75%)

$-0.34 (-2.76%)

95

Hold

$40

$26.48 (195.86%)

$200

1 years 5 months 1 days ago
(14-May-2024)

0/2 (0%)

$6.44 (19.19%)

Buy

1 years 7 months 15 days ago
(29-Feb-2024)

0/1 (0%)

$310 (182.35%)

Hold

$100

$86.48 (639.64%)

1 years 11 months 2 days ago
(13-Nov-2023)

1/2 (50%)

$42.4 (73.61%)

6

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?